Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25128 | (2-Chloro-3-fluoropyridin-4-YL)methanol | 946127-54-4 | ≧98.0% |  |
| 25078 | CFT1946 | 2882165-79-7 | ≧98.0% |  |
| CFT1946 is an investigational, orally bioavailable small molecule degrader of BRAF V6 | ||||
| 25045 | Cavosonstat | 1371587-51-7 | 98% Min. |  |
| Cavosonstat, alos known as N91115) an orally bioavailable inhibitor of S-nitrosogluta | ||||
| 25041 | CC-90003 | 1621999-82-3 | 98% Min. |  |
| CC-90003 is an orally available inhibitor of extracellular signal-regulated kinase (E | ||||
| 24161 | CMP-5 2HCl | 2309409-79-6 | 98% Min. |  |
| CMP-5 is a potent, specific, and selective PRMT5 inhibitor, while displays no activit | ||||
| 24156 | CYD19 | 2415281-52-4 | 98% Min. |  |
| CYD19 is a potent Snail/HDAC dual target inhibitor. | ||||
| 24144 | CPI-455 HCl | 2095432-28-1 | 98% Min. |  |
| CPI-455 is a potent and selective inhibitor of KDM5 demethylases which reduces surviv | ||||
| 24109 | CBR-5884 | 681159-27-3 | ≧98.0% |  |
| CBR 5884 is a phosphoglycerate dehydrogenase (PHGDH) inhibitor which was able to inhi | ||||
| 24101 | Crelosidenib | 2230263-60-0 | 98% Min. |  |
| Crelosidenib is an isocitrate dehydrogenase 1 (IDH1) inhibitor. It is an antineoplast | ||||
| 24095 | CC90001 free base | 1403859-14-2 | 98% Min. |  |
| CC-90001 is a potent and selective JNK inhibitor, which is 12.9-fold more potent for | ||||
| 24064 | Cirtuvivint | 2143917-62-6 | ≧98.0% |  |
| Cirtuvivint is a CDC-like kinase (CLK) and dual-specificity tyrosine-phosphorylation- | ||||
| 24052 | Camonsertib | 2417489-10-0 | 98% Min. |  |
| Camonsertib, also known as RP 3500, is aA Novel, Potent, and Selective ATR Inhibitor | ||||
| 24024 | CVN-293 | 2815296-08-1 | ≧98.0% |  |
| CVN-293 is an oral, brain-penetrant, small-molecule inhibitor of KCNK13. | ||||
| 24022 | 5-chloro-2-methoxypyridine-3-sulfonyl chloride | 1261451-92-6 | ≧98.0% |  |
| 5-chloro-2-methoxypyridine-3-sulfonyl chloride, CAS 1261451-92-6. | ||||
| 20678 | CUR5g | 1370032-20-4 | 98% Min. |  |
| CUR5g is a potent autophagy inhibitor. | ||||
| 20653 | Contezolid free base | 1112968-42-9 | 98% Min. |  |
| Contezolid (Youxitai ®), an orally administered oxazolidinone antibacterial agent, i | ||||
| 20645 | CP-506 ( Synonyms: SN-36506 ) | 2227304-19-8 | 98% Min. | _2227304-19-8.png) |
| CP-506 (SN-36506) is an hypoxia-activated prodrug of a DNA-alkylating nitrogen mustar | ||||
| 20632 | Censavudine | 634907-30-5 | 98% Min. |  |
| Censavudine, also known as OBP-601, BMS-986001 or festinavir, is a nucleoside reverse | ||||
| 20626 | CFI-402257 free base | 1610759-22-2 | 98% Min. |  |
| CFI-402257 was discontinued for commercial reason. | ||||
| 20622 | Cantharidine | 56-25-7 | 98% Min. |  |
| Cantharidine (free base) is a PP1/2A inhibitor found in Canarthis vesicatoria. It inh | ||||
| 20575 | Compound E | 209986-17-4 | 98% Min. |  |
| Compound E is a cell-permeable, potent, selective inhibitor of ɣ-secretase and Notch | ||||
| 20562 | 0990CL | 511514-03-7 | 98% Min. |  |
| 0990CL is an inhibitor of heterotrimeric Gαi subunits. 0990CL showed direct interact | ||||
| 20558 | CBiPES HCl | 856702-40-4 | 98% Min. |  |
| CBiPES HCl is a selective positive allosteric modulator of the mGlu2 receptor. | ||||
| 20555 | COH1 inhibitor | 20217-22-5 | 98% Min. |  |
| COH1 is a ribonucleotide reductase (RR) inhibitor. | ||||
| 20510 | CC-92480 ( Mezigdomide ) | 2259648-80-9 | ≧98.0% |  |
| CC-92480 Is a Novel Cereblon E3 Ligase Modulator with Enhanced Tumoricidal and Immuno | ||||
| 20488 | CYM-50308 | 1345858-76-5 | 98% Min. |  |
| CYM 50308 is a novel agonist of SIP4 (EC50 = 56 nM) that displays 37-fold selectivity | ||||
| 20478 | CRANAD-28 | 1623747-97-6 | 98% Min. |  |
| CRANAD-28 is a blood brain barrier (BBB) penetrable two-photon imaging probe. It acts | ||||
| 20467 | CPPHA | 693288-97-0 | 98% Min. |  |
| CPPHA is a positive allosteric modulator of metabotropic glutamate receptor 5 (mGluR5 | ||||
| 20455 | Camlipixant ( BLU-5937 ) | 1621164-74-6 | ≧98.0% | _1621164-74-6.png) |
| Camlipixant is an investigational, twice-daily oral P2X3 receptor antagonist for the | ||||
| 20441 | CMP3a | 647834-15-9 | 98% Min. |  |
| CMP3a is a NEK2 kinase inhibitor. CMP3a efficiently attenuated GBM growth in a mouse | ||||